Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 3 , Pages 349-358, June 2010

Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection

  • Sara Raimondi (Researcher)

      Affiliations

    • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
  • ,
  • Albert B. Lowenfels (Professor of Surgery)

      Affiliations

    • New York Medical College Valhalla, NY 10595, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 914 594 4260; fax: +1 914 594 3481.
  • ,
  • Antonio M. Morselli-Labate (Research Fellow)

      Affiliations

    • Department of Digestive Diseases and Internal Medicine, S. Orsola-Malpighi Hospital, Bologna, Italy
  • ,
  • Patrick Maisonneuve (Head of Department)

      Affiliations

    • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
  • ,
  • Raffaele Pezzilli (Head of Pancreas Unit)

      Affiliations

    • Department of Digestive Diseases and Internal Medicine, S. Orsola-Malpighi Hospital, Bologna, Italy

Acute pancreatitis, chronic pancreatitis and pancreatic cancer are responsible for most of the burden of exocrine pancreatic disease. Glandular damage from recurrent bouts of acute pancreatitis can lead to irreversible changes characteristic of chronic pancreatitis. In recent decades accumulating evidence has defined longstanding pre-existing chronic pancreatitis as a strong risk factor for pancreatic cancer. The lag period between diagnosis of chronic pancreatitis and pancreatic cancer is usually one or two decades: pancreatitis appearing a year or two before the diagnosis of pancreatic cancer is often the result of tumour-related ductal obstruction. The risk of developing pancreatic cancer appears to be highest in rare types of pancreatitis with an early onset, such as hereditary pancreatitis and tropical pancreatitis. Even though there is a strong link between chronic pancreatitis and pancreatic cancer, over a 20 year period only around five percent of patients with chronic pancreatitis will develop pancreatic cancer. Until the development of more sophisticated screening procedures, screening is not recommended for patients with chronic pancreatitis.

Keywords: Pancreas, Pancreatic cancer, Pancreatitis, Acute pancreatitis, Chronic pancreatitis, Hereditary pancreatitis, Tropical pancreatitis, Epidemiology, Kras

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by grants from Solvay Pharmaceuticals, and the C.D. Smithers Foundation.

PII: S1521-6918(10)00021-1

doi:10.1016/j.bpg.2010.02.007

Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 3 , Pages 349-358, June 2010